The former Emory University professor, who now works at the University of Miami, came to the committee’s attention because he was accepting sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug.
According to Ed Silverman, an update on that investigation should be coming this June. Nemeroff was found to have received millions from pharmaceuticals all while he made favorable reviews of the drugs of these pharmaceutical companies, and he rarely disclosed this conflict. Emory University was also found to have covered up this conflict after the fact.
No comments:
Post a Comment